These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 210104)

  • 21. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours.
    Saied EM; El-Etreby NM
    Ann Diagn Pathol; 2017 Apr; 27():62-68. PubMed ID: 28325363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant transformation of mucinous ovarian cystadenomas of intestinal epithelial type.
    Szymańska K; Szamborski J; Miechowiecka N; Czerwiński W
    Histopathology; 1983 Jul; 7(4):497-509. PubMed ID: 6884997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary Krukenberg tumor of ovary. Review of literature and case report.
    Joshi VV
    Cancer; 1968 Dec; 22(6):1199-207. PubMed ID: 4303165
    [No Abstract]   [Full Text] [Related]  

  • 24. Histochemical study of mucinous ovarian cystomas of intestinal and mixed types: O-acetylated sialomucin content in relation to biologic behavior.
    Fulcheri E; Baracchini P; Foglia G; Lapertosa G; Siciliano B; Ragni N
    Tumori; 1990 Feb; 76(1):73-6. PubMed ID: 2321278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Borderline mixed epithelial tumor of the ovary].
    Osadchaia VV
    Arkh Patol; 1980; 42(10):56-8. PubMed ID: 7447744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphometric data to FIGO stage and histological type and grade for prognosis of ovarian tumours.
    Baak JP; Wisse-Brekelmans EC; Langley FA; Talerman A; Delemarre JF
    J Clin Pathol; 1986 Dec; 39(12):1340-6. PubMed ID: 3805319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Composite mucinous ovarian neoplasms associated with Sertoli-Leydig and carcinoid tumors.
    Waxman M; Damjanov I; Alpert L; Sardinsky T
    Cancer; 1981 Apr; 47(8):2044-52. PubMed ID: 6261934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk for malignant and borderline ovarian neoplasms following basic preoperative evaluation by ultrasonography, ca125 level and age.
    Karadag B; Kocak M; Kayikcioglu F; Ercan F; Dilbaz B; Kose M; Haberal A
    Asian Pac J Cancer Prev; 2014; 15(19):8489-93. PubMed ID: 25339052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of morphometry in ovarian epithelial tumors of borderline malignancy.
    Baak JP; Fox H; Langley FA; Buckley CH
    Int J Gynecol Pathol; 1985; 4(3):186-91. PubMed ID: 2997053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Müllerian and mesothelial lymph node involvement in patients with borderline ovarian tumors.
    Eltabbakh GH; Mount SL
    J Reprod Med; 2011; 56(5-6):211-8. PubMed ID: 21682116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psammoma bodies in serous carcinoma of the ovary. A prognostic study.
    Aure JC; Hoeg K; Kolstad P
    Am J Obstet Gynecol; 1971 Jan; 109(1):113-8. PubMed ID: 4321483
    [No Abstract]   [Full Text] [Related]  

  • 33. Mucinous tumors of the ovary. A clinicopathologic study of 70 cases.
    Chaitin BA; Gershenson DM; Evans HL
    Cancer; 1985 May; 55(9):1958-62. PubMed ID: 2983869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and histologic studies of ovarian carcinoma. Long-term follow-up of 990 cases.
    Aure JC; Hoeg K; Kolstad P
    Obstet Gynecol; 1971 Jan; 37(1):1-9. PubMed ID: 4321469
    [No Abstract]   [Full Text] [Related]  

  • 35. Biologic behavior of primary ovarian malignancy.
    Julian CG; Goss J; Blanchard K; Woodruff JD
    Obstet Gynecol; 1974 Dec; 44(6):873-84. PubMed ID: 4373686
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
    Strickland S; Parra-Herran C
    Histopathology; 2016 Jun; 68(7):977-87. PubMed ID: 26542609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of metallothionein and nuclear size in discrimination of malignancy in mucinous ovarian tumors.
    Tan Y; Sinniah R; Bay BH; Singh G
    Int J Gynecol Pathol; 1999 Oct; 18(4):344-50. PubMed ID: 10542943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and prognosis of mucinous tumors of the ovary.
    Kikkawa F; Nawa A; Kajiyama H; Shibata K; Ino K; Nomura S
    Gynecol Oncol; 2006 Oct; 103(1):171-5. PubMed ID: 16546243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucinous tumors of the ovary: a review.
    Hart WR
    Int J Gynecol Pathol; 2005 Jan; 24(1):4-25. PubMed ID: 15626914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases.
    Guerrieri C; Högberg T; Wingren S; Fristedt S; Simonsen E; Boeryd B
    Cancer; 1994 Oct; 74(8):2329-40. PubMed ID: 7922984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.